Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer

Head and Neck

Volumn 26, Issue 5, 2004, Pages 447-455

  Argiris, Athanassios ^a   Stenson, Kerstin M ^b   Brockstein, Bruce E ^a,c   Mittal, Bharat B ^a   Pelzer, Harold ^a   Kies, Merrill S ^a   Jayaram, Prathima ^a   Portugal, Louis ^d   Wenig, Barry L ^a,c   Rosen, Fred R ^d   Haraf, Daniel J ^b   Vokes, Everett E ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b University of Chicago   (United States)

^c EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chemotherapy; Head and neck cancer; Neck dissection; Radiotherapy; Squamous cell carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NECK DISSECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; MULTICENTER STUDIES; NECK DISSECTION; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2342533221     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10394     Document Type: Article

References (23)

1. Argiris A. Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol 2002;14:323-329.
2. Adelstein DJ, Saxton JP, Lavertu P, et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 2002;20:1405-1410.
3. Vokes EE, Kies MS, Haraf DJ, et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000;18:1652-1661.
4. Ready N, Chougule P, Nadeem A, et al. Induction weekly paclitaxel and carboplatin followed by concurrent paclitaxel, carboplatin and radiotherapy in advanced head and neck squamous cell cancers. Proc Am Soc Clin Oncol 2002;21:A943.
5. Machtay M, Rosenthal DI, Hershock D, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 2002;20:3964-3971.
6. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997;19:559-566.
7. Sanguineti G, Corvo R, Benasso M, et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 1999;21:223-228.
8. Clayman GL, Johnson CJ II, Morrison W, Ginsberg L, Lippman SM. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001;127:135-139.
9. Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992;102:934-939.
10. Corry J, Smith JG, Peters LJ. The concept of a planned neck dissection is obsolete. Cancer J 2001;7:472-474.
11. Peters LJ, Weber RS, Morrison WH, et al. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996;18:552-559.
12. Mendenhall WM, Villaret DB, Amdur RJ, et al. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2002;24:1012-1018.
13. Su CK, Bhattacharya J, Wang CC. Role of neck surgery in conjunction with radiation in regional control of node-positive cancer of the oropharynx. Am J Clin Oncol 2002;25:109-116.
14. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000;126:950-956.
15. Kies MS, Haraf DJ, Rosen F, et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001;19:1961-1969.
16. Rosen FR, Haraf D, Kies MS, et al. Multicenter randomized phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. Clin Cancer Res 2003;9:1689-1697.
17. Armstrong J, Pfister D, Strong E, et al. The management of the clinically positive neck as part of a larynx preservation approach. Int J Radiat Oncol Biol Phys 1993;26:759-765.
18. Argiris A, Haraf DJ, Kies MS, Vokes E. Intensive concurrent chemoradiotherapy with 5-FU-and hydroxyurea-based regimens: reversing a pattern of failure. Oncologist 2003;8:350-360.
19. Tupchong L, Scott CB, Blitzer PH, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 1991;20:21-28.
20. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.
21. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiochemotherapy in high-risk SCCA of the head and neck: initial report of RTOG 9501/intergroup phase III trial. Proc Am Soc Clin Oncol 2002;21:A903.
22. Boyd TS, Harari PM, Tannehill SP, et al. Planned post-radiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 1998;20:132-137.
23. Strasser MD, Gleich LL, Miller MA, Saavedra HI, Gluckman JL. Management implications of evaluating the N2 and N3 neck after organ preservation therapy. Laryngoscope 1999;109:1776-1780.